White Matter Hyperintensities Characterized in Dementia
THURSDAY, Feb. 18, 2021 -- Volumes of white matter hyperintensities (WMH) are larger in behavioral-variant frontotemporal dementia (bvFTD) than in Alzheimer disease (AD), and larger volumes are associated with disease severity in bvFTD, according to a study published online Feb. 17 in Neurology.
Katherine Huynh, from the University of Sydney in Australia, and colleagues conducted a cross-sectional brain magnetic resonance imaging (MRI) study with volumetric and voxel-wise analyses. A total of 129 patients (64 with bvFTD and 65 with AD) and 66 controls underwent high-resolution MRI as well as clinical and neuropsychological examination. In 124 cases (54 bvFTD, 44 AD, and 26 controls), genetic screening was conducted and postmortem pathology was available for 18 cases (13 bvFTD and five AD).
The researchers found that compared with patients with AD and controls, patients with bvFTD had larger total WMH volumes. WMH volumes were associated with disease severity, but not vascular risk, in bvFTD. Distinct spatial patterns of WMH were seen in bvFTD and AD, which mirrored characteristic patterns of cortical atrophy. There was an association noted for regional WMH load with worse cognitive performance in discrete cognitive domains. WMH-related cognitive impairments were shared between syndromes; additional associations were seen in bvFTD.
"White matter hyperintensities should be viewed as a core feature of frontotemporal dementia and Alzheimer's disease that can contribute to cognitive problems, not simply a marker of vascular disease," a coauthor said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
TUESDAY, March 2, 2021 -- Both prediabetes and known type 2 diabetes are associated with a heightened risk for vascular dementia, cognitive decline, and Alzheimer disease (AD),...
MONDAY, March 1, 2021 -- Very short sleep durations and poor-quality sleep in the elderly increase the risk for developing dementia and earlier death, according to a study...
THURSDAY, Feb. 18, 2021 -- Male homeostatic iron regulator HFE gene p.C282Y homozygotes have an increased risk for incident dementia, according to a study published online Feb. 2...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.